Introduction {#sec1}
============

Coronavirus 2019 (COVID-19) pandemic is the defining global health crisis in recent times. Although this disease is predominantly a respiratory illness with pulmonary manifestations, it has far reaching consequences in other systems. There is increasing evidence to support COVID-19 related coagulopathy. The commonly observed association is linked to arterial and venous thrombotic events.[@bib1], [@bib2], [@bib3]

To date, there are only four case reports on superior mesenteric artery thrombosis[@bib4], [@bib5], [@bib6], [@bib7]. In the available literature, only two other cases of superior mesenteric vein thrombosis associated with COVID-19 have been described[@bib7] ^,^ [@bib8]. We present a peculiar case of high grade small bowel obstruction secondary to congenital adhesion band with associated focal bowel ischemia contributed by superior mesenteric vein thrombosis and positive lupus anticoagulant in a patient with COVID-19.

Case Report {#sec2}
===========

We report a case of a 30 year-old Bangladeshi male with no significant past medical or surgical history. He first presented to a public hospital with a 2 days history of colicky abdominal pain that was associated with vomiting. Chest X-ray showed left lower zone airspace opacities and nasopharyngeal swabs SARS-CoV-2 polymerase chain reaction confirmed COVID-19 infection. A computed tomography scan of the abdomen and pelvis revealed superior mesenteric vein thrombosis with diffuse mural thickening and fat stranding of multiple jejunal loops ([Figure 1](#fig1){ref-type="fig"} ). Coagulation profile tests showed positive lupus anticoagulant, mildly raised fibrinogen of 4.65g/L, and a markedly raised D-dimer of more than 20.0μg/mL despite normal prothrombin time and activated partial thromboplastin time. These are in keeping with COVID-19 related coagulopathy.[@bib9] His clinical condition remained stable and he was started on twice-daily low molecular weight heparin at 1mg/kg therapeutic dosage. After 17-day length of stay, he was discharged to a community isolation facility with a plan for 3 months of low molecular weight heparin as per physician and patient preference.Figure 1Superior mesenteric vein thrombosis (bold arrow) and diffuse mural thickening (dotted arrow)

This patient re-presented to our tertiary hospital a month later for 2 days duration of generalized abdominal pain associated with multiple episodes of bilious vomiting. He reported strict compliance to the twice-daily enoxaparin sodium injections. His vital signs were normal and examination findings revealed a distended abdomen with no sign of peritonism noted. A computed tomography scan of the abdomen and pelvis revealed proximal small bowel with a transition point seen in mid jejunum ([Figure 2](#fig2){ref-type="fig"} ). There was no intra-abdominal mass or radiological features of ischemia detected. There was partial recanalization of the superior mesenteric vein thrombosis with normal opacification proximal and distal to the thrombosis. He was resuscitated with intravenous fluids and a nasogastric tube was inserted for prompt decompression of the stomach.Figure 2High grade small bowel obstruction with a transition point (bold arrow) seen in mid jejunum.

In view of the high grade small bowel obstruction ([Figure 2](#fig2){ref-type="fig"}), the patient underwent urgent exploratory laparotomy. Intra-operative findings revealed distended proximal small bowel with a single congenital adhesion band at the root of the mesentery 40cm distal to duodenojejunal flexure ([Figure 3](#fig3){ref-type="fig"} ) causing a tight stenosis of mid jejunum. The congenital adhesion band was excised and this revealed a short segment of severely strictured small bowel. The rest of the small bowel was noted to be healthy and viable. The segment of small bowel stricture was resected with primary anastomosis performed. Post-operative recovery was uncomplicated and he was recommenced on his enoxaparin sodium on post-operative day 2. He made a good recovery and was discharged back to community isolation facility on post-operative day 7. Histology of the small bowel specimen resected revealed ischemic bowel with presence of organizing thrombosis within large mesenteric venous vessels.Figure 3Congenital adhesion band (left). Strictured small bowel in mid jejunum (middle). Resected small bowel specimen (right).

Discussion {#sec3}
==========

A congenital adhesion is an uncommon surgical condition causing intestinal obstruction. It is described as an intraperitoneal adhesion that is considered congenital with no relation to previous surgery or inflammatory process. We hypothesized the acute presentation of intestinal obstruction in this patient to be due to a congenital adhesion band exacerbated by small bowel stricture that was contributed by superior mesenteric vein thrombosis related to COVID-19. The focal short segment transition point in mid jejunum was not demonstrated in this patient's earlier computed tomography scan a month ago when he was admitted for superior mesenteric thrombosis related to COVID-19. The described fat stranding and diffuse mural thickening seen in jejunal loops in the earlier scan may be related to acute venous congestion. Superior mesenteric vein thrombosis causing venous ischemia and small bowel stricture has been described in scattered case reports in non-COVID patients.[@bib10] ^,^ [@bib11] Acute thrombosis of superior mesenteric vein does not allow sufficient time for collateral circulation to develop. Despite therapeutic anticoagulation, secondary arterial spasms may occur leading to bowel ischemia, transmural infarction, and development of bowel stricture. In this patient, the choice of anticoagulation was enoxaparin sodium. This reduces the frequency of monitoring required to maintain an adequate therapeutic level of anticoagulation in this climate of COVID-19.

The pathophysiology of COVID-19 related coagulopathy can be principally attributed to Virchow's triad of thrombosis.[@bib12] Firstly, endothelial injury may be caused by SARS-CoV2 virus that binds via ACE2 receptors on endothelial cells. Secondly, a hypercoagulable state can result from a dysregulated hyperinflammatory response to the viral infection. Thirdly, stasis of blood can be a consequence of immobilization in critically ill patients.[@bib12] Antiphospholipid syndrome is an autoimmune disease with hypercoagulable state caused by the presence of antiphospholipid antibodies which predisposes the patient to having vascular thrombosis. The presence of a lupus anticoagulant in patients with COVID-19 is not uncommon, and in our case the patient did have a concurrent lupus anticoagulant together with a hypercoagulable state. These antibodies can also arise transiently in patients with critical illness and viral infections. In a case control study by Louise Bowles et al, among patients with prolonged activated partial thromboplastin time, lupus anticoagulant was significantly higher in COVID-19 patients (91%) compared to control group (26%).[@bib13] In another study performed in Mulhouse France, 25 out of 56 patients (45%) with COVID-19 were tested positive for lupus anticoagulant.[@bib14] Antiphospholipid syndrome will need to be excluded in this patient with repeat testing for lupus anticoagulant at least 12 weeks after initial testing.

Conclusion {#sec4}
==========

This peculiar case report underscores a few important learning points. One, COVID-19 is a systemic disease not limited to pulmonary manifestations and complications. Two, treating clinicians must be aware of the hypercoagulable state of COVID-19 patients and judicious use of prophylactic anticoagulation in hospitalized patients should be considered. And lastly, one must consider the rare differential of mesenteric vein thrombosis and its related sequelae of mesenteric ischemia in a patient with COVID-19 who presents with abdominal pain.
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